| SC 13G/A | 2024-04-10 | Capital International Investors | CRISPR Therapeutics AG | 8,223,994 | 10.2% | EDGAR |
| SC 13G/A | 2024-02-12 | Nikko Asset Management Americas, Inc. | CRISPR Therapeutics AG | 3,369,762 | 4.2% | EDGAR |
| SC 13G/A | 2024-02-09 | Capital International Investors | CRISPR Therapeutics AG | 6,420,736 | 8.1% | EDGAR |
| SC 13G/A | 2024-02-05 | Sumitomo Mitsui Trust Holdings, Inc. | CRISPR Therapeutics AG | 3,369,762 | 4.2% | EDGAR |
| SC 13G/A | 2024-01-29 | ARK Investment Management LLC | CRISPR Therapeutics AG | 8,536,104 | 10.8% | EDGAR |
| SC 13G/A | 2024-01-10 | ARK Investment Management LLC | CRISPR Therapeutics AG | 8,536,104 | 10.8% | EDGAR |
| SC 13G/A | 2023-04-11 | ARK Investment Management LLC | CRISPR Therapeutics AG | 7,990,188 | 10.2% | EDGAR |
| SC 13G | 2023-02-13 | Capital International Investors | CRISPR Therapeutics AG | 5,560,492 | 7.1% | EDGAR |
| SC 13G/A | 2023-02-10 | ARK Investment Management LLC | CRISPR Therapeutics AG | 7,829,932 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-10 | Nikko Asset Management Americas, Inc. | CRISPR Therapeutics AG | 4,006,476 | 5.1% | EDGAR |
| SC 13G/A | 2023-02-03 | Sumitomo Mitsui Trust Holdings, Inc. | CRISPR Therapeutics AG | 4,006,476 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-14 | Nikko Asset Management Americas, Inc. | CRISPR Therapeutics AG | 4,319,471 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-11 | Capital International Investors | CRISPR Therapeutics AG | 3,706,004 | 4.8% | EDGAR |
| SC 13G/A | 2022-02-09 | ARK Investment Management LLC | CRISPR Therapeutics AG | 9,087,868 | 11.9% | EDGAR |
| SC 13G/A | 2022-02-04 | Sumitomo Mitsui Trust Holdings, Inc. | CRISPR Therapeutics AG | 4,319,471 | 5.6% | EDGAR |
| SC 13G/A | 2021-09-10 | ARK Investment Management LLC | CRISPR Therapeutics AG | 7,644,350 | 10.0% | EDGAR |
| SC 13G/A | 2021-08-10 | Capital International Investors | CRISPR Therapeutics AG | 4,265,002 | 5.6% | EDGAR |
| SC 13D/A | 2021-02-16 | Versant Ventures IV, LLC | CRISPR Therapeutics AG | 1,336,088 | 1.9% | EDGAR |
| SC 13G/A | 2021-02-16 | ARK Investment Management LLC | CRISPR Therapeutics AG | 10,412,976 | 14.6% | EDGAR |
| SC 13G/A | 2021-02-16 | Capital International Investors | CRISPR Therapeutics AG | 7,626,355 | 10.7% | EDGAR |